Freund Report

The report covers FREUND CORPORATION's record-high net sales for FY2023, driven by strong demand in the pharmaceutical sector and expansion into non-pharmaceutical fields. It highlights the launch of local operations in China, the rebranding of overseas subsidiaries, and the establishment of a global five-pillar structure. The company achieved its highest-ever net sales and order backlog in both machinery and chemical business segments, with strong performance in pharmaceutical excipients and food preservatives. The report also details the 9th Medium-term Management Plan and long-term vision, including investment plans and sustainability initiatives.

Report type

Annual Report

Class

Financial

Scope

Full report

Fiscal year

2024

Period

1 March 2023 – 29 February 2024

Language

English

Pages

 

File size